Lallemand Animal Nutrition
Australia - English   [ change ]

COVID-19 Info
We would like to inform our customers and partners that we are making every effort to ensure the continuity of our services during this time. We applied contingency plans to our production facilities, and — to date — our production is running under strict safety measures to protect the health of our staff. We will keep our customers informed as the situation evolves.

Our R&D process

Our research and development process spans from discovery to customer use. We operate a three-step discovery process based on a wide array of technologies and skills, evolving towards molecular microbiology and omics techniques.

1. Discovery and proof of concept:

  • Strain screening and selection
    • Functional assays
    • Lallemand Aquapharm screening platform
    • >12,500 strains
    • Ecosystem-specific microbial collections
  • Strain characterization and safety
    • Strain identity: whole-genome sequencing
    • Antibiotic-resistant genes, presence of mobile genetic elements
    • Microbial fractions characterization
    • Functional properties
  • Development of models and methods
    • Functional microarrays
    • Quantitative real-time PCR
    • Dynamic in vitro models
    • Diverse type of biomarkers
  • In vitro/in vivo proof of concept
    • Proof of concept animal and silage trials
  • Mini silos trials for forage inoculants

2. Scale-up and registration

  • Production scale-up, process optimization
    • Internal process optimization and scale-up team
    • Internal pilot plants
    • State of the art analytical tools: cytometry, cryomicroscopy, differential scanning calorimetry (DSC)
  • Product stability and applicability
    • Product formulation optimization
    • Internal pilot feed processing unit
    • Strain and matrix specific analytical methods
    • Next generation microbial cell counters
  • In vivo efficacy assessment
    • Strong collaboration network with research partners to conduct efficacy trials in all livestock species (ruminant, swine, poultry, aquaculture…), companion animals and equine.
    • Dedicated large experimental bunker units for forage inoculants
  • Products registration
    • Dedicated team of territory specific specialists for the preparation of regulatory dossiers

3. Product Deployment

  • Modes of action investigation to strengthen product documentation
    • Focus on the role of our solutions on microbial ecosystems and associated impact on animal response, such as performance, welfare, immunity, oxidative stress, metabolism etc.
    • Controlled in vitro, ex vivo and in vivo studies to understand modes of action for strains in order to optimize and extend applications
    • Application of novel biomarkers and sensors to assess products effects beyond animal performance (e.g. animal welfare)
  • Applied trials
    • Controlled large scale trials
    • Pilot farms network in ruminants, swine, poultry, and aquaculture
  • Development of audit tools and on-farm services